METHODS OF APPLYING OF APO-2L-RECEPTORS AGONISTS AND NK-CELLS ACTIVATORS Russian patent published in 2010 - IPC A61K38/19 A61P35/00 A61P31/00 

Abstract RU 2395294 C2

FIELD: medicine.

SUBSTANCE: group of inventions relates to experimental medicine and can be applied for amplification of apoptosis or cytolytic activity in cells of mammals. Method and application by invention include bringing mammalian cells in contact with effective quantity of Apo- 2-ligand receptors agonist and resting or unprocessed NK-cells, said agonist is selected from Apo-2-ligand polypeptide, agonistic DR5 antibody and agonistic DR4 antibody.

EFFECT: application of inventions allows amplification of apoptosis and cytolysis induction in tumour cells due to activation by Apo-2-ligand receptors agonist of resting NK-cells.

26 cl, 1 tbl, 18 dwg, 5 ex

Similar patents RU2395294C2

Title Year Author Number
APOPTOSIS DETECTION TECHNIQUES AND REAGENTS 2007
  • Ostin Kehri D.
  • Lorens Dehvid A.
  • Ashkenazi Avi
RU2450273C2
ANALYSES AND METHODS OF BIOMARKER APPLICATION 2006
  • Vagner Klaus V.
  • Ashkenazi Avi Dzh.
RU2409817C2
ANALYSES AND METHODS USING BIOMARKERS 2005
  • Vagner Klaus V.
RU2410438C2
APOPTOTIC Apo2L/TRAIL SENSITIVITY BY TESTING GalNac-T14 EXPRESSION IN CELLS/TISSUES 2006
  • Vagner Klaus V.
  • Ashkenazi Avi Dzh.
RU2416097C2
ANALYSES AND METHODS WITH APPLICATION OF BIOMARKERS 2005
  • Vagner Klaus V.
RU2431676C2
DR5 ANTIBODIES AND USE THEREOF 2006
  • Adams Kamellija V.
RU2458072C2
COMBINATION OF APO2L/TRAIL AND EGFR INHIBITOR FOR CANCER TREATMENT, METHOD IN VITRO OF APOPTOSIS INCREASE AND APPLICATION OF COMBINATION FOR OBTAINING MEDICATION FOR CANCER TREATMENT 2006
  • Ashkenazi Avi Dzh.
RU2429006C2
METHOD OF PURIFYING APO-2 LIGAND/TRAIL VIA COLD CRYSTALLISATION 2006
  • Flores Khiter
  • Lin Tanja P.
  • Mehtt'Juz Timoti K.
  • Paj Rodzher
  • Shakhrokkh Zakhra
RU2435781C2
COMPOSITIONS OF ANTIBODIES 2005
  • Ehnd'Ja Dzhejms D.
  • Gvi Shian K.
  • Lju Tszjun'
  • Shehn' E
RU2426554C2
ANTIBODY SELECTIVE TO APOPTOSIS INDUCING LIGAND RECEPTOR ASSOCIATED WITH TUMOR NECROSIS FACTOR, AND USES THEREOF 2001
  • Zou Tong
  • Itikava Kimikhisa
  • Kimberli Robert P.
  • Kupman Uill'Jam Dzh.
RU2298013C2

RU 2 395 294 C2

Authors

Godovski Pol Dzh.

Satial Sandzhiv Kh.

Dates

2010-07-27Published

2005-06-15Filed